| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Shakil Aslam | Chief Medical Officer | 2026-05-20 | 4,518 | $0.82 | $3.72kSell |
| Badri N. Dasu | Chief Engineering Officer | 2026-04-02 | 2,444 | $0.72 | $1.76kSell |
| Vincent J. Angotti | CHIEF EXECUTIVE OFFICER | 2026-04-02 | 9,938 | $0.72 | $7.18kSell |
| Raffi Asadorian | Chief Financial Officer | 2026-04-02 | 2,444 | $0.72 | $1.76kSell |
| Shakil Aslam | Chief Medical Officer | 2026-04-02 | 2,118 | $0.72 | $1.53kSell |
| Vincent J. Angotti | CHIEF EXECUTIVE OFFICER | 2026-03-13 | 213,310 | $0.59 | $125.00kBuy |
| Vincent J. Angotti | CHIEF EXECUTIVE OFFICER | 2026-02-14 | 9,559 | $0.79 | $7.58kSell |
| Badri N. Dasu | Chief Engineering Officer | 2026-02-14 | 2,346 | $0.79 | $1.86kSell |
| Raffi Asadorian | Chief Financial Officer | 2026-02-14 | 2,933 | $0.79 | $2.33kSell |
| Shakil Aslam | Chief Medical Officer | 2026-02-12 | 35,000 | $0.81 | $28.42kBuy |
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Perceptive Advisors LLC | 19.11% | 9,920,138 | $11.51M | Insider |
| Cormedix Inc | 17.51% | 9,090,909 | $10.55M | Insider |
| Mark A. Wan | 15.34% | 7,964,082 | $9.24M | Insider |
| Guy P. Nohra | 10.22% | 5,302,881 | $6.15M | Insider |
| Three Arch Management IV LLC | 7.22% | 3,749,918 | $4.35M | Insider |
| Three Arch Management III LLC | 7.01% | 3,637,169 | $4.22M | Insider |
| Stephen J. Hoffman | 5.56% | 2,885,892 | $3.35M | Insider |
| Skyline Venture Partners Qualified Purchaser Fund IV L P | 5.53% | 2,871,933 | $3.33M | Insider |
| Acp IV LP | 5.38% | 2,794,907 | $3.24M | Insider |
| Nantahala Capital Management LLC | 3.84% | 1,992,519 | $2.31M | Insider |